Head‐to‐head comparison of genotyping of human papillomavirus by GP5+/6+‐PCR‐based reverse dot blot hybridization assay and SPF10‐PCR‐based line probe assay-Reference-Cited by-同舟云学术

Head‐to‐head comparison of genotyping of human papillomavirus by GP5+/6+‐PCR‐based reverse dot blot hybridization assay and SPF10‐PCR‐based line probe assay

Published:2023-01-09 Issue:2 Volume:95 Page:
ISSN:0146-6615
Container-title:Journal of Medical Virology
language:en
Short-container-title:Journal of Medical Virology

Author:

Yin Jian¹²^ORCID,Peng Siying²³,Li Xinyue²⁴,Zhang Changning²⁴,Hu Fangfang²³,Chen Wen²^ORCID,Qiao Youlin¹

Affiliation:

1. School of Population Medicine and Public Health Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China

2. Department of Cancer Epidemiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China

3. The State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Collaborative Innovation Center of Biologic Products Xiamen University Xiamen China

4. College of Life Sciences Hebei University Baoding China

Publisher

Wiley

Subject

Infectious Diseases,Virology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmv.28435

Reference34 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. Incidence and mortality of cervical cancer in China in 2015

3. Cancer incidence and mortality in China, 2015

4. Clinical significance of human papillomavirus genotyping

5. Prospective Study of Human Papillomavirus (HPV) Types, HPV Persistence, and Risk of Squamous Cell Carcinoma of the Cervix